StockData
Cryoport, Inc. logo

Cryoport, Inc. (CYRX) stock

CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$19.74−0.06 (-0.30%)

Close on Nov 17, 2026Market cap $999.81MP/E –Yield –

Cryoport price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cryoport's price to sales ratio was 5.6× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.6× to 12.7×, with a median of 3.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.6×+2.8
2025Dec 31, 20252.8×+0.6
2024Dec 31, 20242.2×−1.0
2023Dec 29, 20233.2×−0.4
2022Dec 30, 20223.6×−9.1
2021Dec 31, 202112.7×−30.5
2020Dec 31, 202043.2×+23.8
2019Dec 31, 201919.4×−35.4
2018Dec 31, 201854.8×+36.9
2017Dec 29, 201717.9×+11.1
2016Dec 30, 20166.7×+4.1
2015Dec 31, 20152.7×−5.2
2014Dec 31, 20147.9×−2.8
2013Dec 31, 201310.7×−23.1
2012Dec 31, 201233.7×−62.0
2011Dec 30, 201195.7×–

More Cryoport figures

See a number that looks wrong?